Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005201079 | SCV005838690 | pathogenic | Neurofibromatosis, type 1 | 2024-06-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Lys2712Valfs*3) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with neurofibromatosis type 1 (PMID: 10607834). For these reasons, this variant has been classified as Pathogenic. |